SURMODICS INC
SRDXHealthcare · Surgical & Medical Instruments & Apparatus · MN · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $126.1M | $132.6M | $100.0M | $105.1M | $94.9M | $100.1M |
| Operating income | −$5.6M | $5.2M | −$22.1M | $6.7M | −$1.3M | $6.5M |
| Net income | −$11.5M | −$1.5M | −$27.3M | $4.2M | $1.1M | $7.6M |
| Total assets | $178.6M | $185.7M | $158.4M | $194.6M | $168.8M | $159.9M |
| Total liabilities | $59.7M | $65.8M | $50.0M | $54.5M | $37.7M | $37.3M |
| Equity | $118.9M | $119.9M | $108.4M | $140.1M | $131.1M | $122.5M |
| EPS (diluted) | $-0.82 | $-0.11 | $-1.96 | $0.30 | $0.08 | $0.55 |
| Shares out. | 14.3M | 14.2M | 14.0M | 13.9M | 13.7M | 13.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- −4.5%
- Net margin
- −9.2%
- Return on equity
- −9.7%
- Return on assets
- −6.5%
- Return on capital (ROCE)
- −3.6%
- Liabilities / assets
- 33.4%
- Debt / equity
- 0.50×
- Book value / share
- $8.30
- Revenue growth (YoY)
- −4.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Altman Z″ (distress)
- 5.49safe
- Accruals / assets
- −6.6%clean
- Beneish M-Score
- -2.52normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Feb 10, 2012
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Trium Capital LlpPassive (13G)Nov 20, 2025
- Gamco Investors, Inc. Et AlActivist (13D)Nov 20, 2025
- Soleus Capital Master Fund, L.P.Passive (13G)Nov 7, 2025
- Alliancebernstein L.P.Passive (13G)May 14, 2025
- Barclays PlcPassive (13G)May 13, 2025
- Beryl Capital Management LlcPassive (13G)Feb 13, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Nov 14, 2025 | 474,950 | 1.0 | +6.2% |
| Oct 31, 2025 | 447,402 | 5.5 | +11.7% |
| Oct 15, 2025 | 400,421 | 3.9 | +22.9% |
| Sep 30, 2025 | 325,821 | 2.1 | -2.1% |
| Sep 15, 2025 | 332,899 | 2.3 | -13.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsNov 19, 2025
- Regulation FD disclosureNov 12, 2025
- Results of operationsAug 8, 2025
- Other material eventJul 2, 2025
- Results of operationsApr 30, 2025
- Regulation FD disclosureMar 7, 2025
- Shareholder voteFeb 10, 2025
- Results of operationsJan 30, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.